Fennec Pharmaceuticals Overview
Latest PEG ratio for Fennec Pharmaceuticals: 47.69 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow47.69
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for FENC is 47.69. That is above the Healthcare sector average of 27.75. Investors often review this figure alongside Fennec Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, FENC currently prints 47.69 for PEG ratio, while the sector average sits near 27.75. That is roughly 71.8% above the sector mean. Large gaps often invite a closer look at Fennec Pharmaceuticals's growth, margins, and balance sheet.
A PEG ratio of 47.69 for Fennec Pharmaceuticals is not 'good' or 'bad' on its own. Compare it with the peer average (27.75) and with FENC's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting FENC's PEG ratio (47.69), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Fennec Pharmaceuticals's PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
